Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MASP2 | O00187 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.49 |
| ▸ | F2 | P00734 | 15/20 | 0.47 |
| ▸ | F11 | P03951 | 3/20 | 0.44 |
| ▸ | KLKB1 | P03952 | 2/20 | 0.42 |
| ▸ | F9 | P00740 | 1/20 | 0.42 |
| ▸ | F10 | P00742 | 1/20 | 0.42 |
| ▸ | PLAT | P00750 | 1/20 | 0.42 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.42 |
| ▸ | F7 | P08709 | 1/20 | 0.42 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.42 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6078150 | 0.86 | F2 (0.47) | MASP2F2 | |
| SCHEMBL6078688 | 0.86 | MASP2 (0.53) | MASP2CYP3A4F2F11KLKB1 | |
| SCHEMBL6078787 | 0.82 | F2 (0.57) | MASP2CYP3A4F2F11KLKB1 | |
| SCHEMBL6078779 | 0.82 | F2 (0.57) | MASP2CYP3A4F2F11KLKB1 | |
| SCHEMBL6078556 | 0.80 | MASP2 (0.61) | MASP2CYP3A4F2F11KLKB1 | |
| SCHEMBL23490530 | 0.78 | MASP2 (0.66) | MASP2CYP3A4F2F11KLKB1 | |
| SCHEMBL6078904 | 0.78 | MASP2 (0.57) | MASP2CYP3A4F2F11KLKB1 | |
| Hydrochloric Acid SCHEMBL23452306 | 0.77 | MASP2 (0.65) | MASP2CYP3A4F2F11KLKB1 | |
| Hydrochloric Acid SCHEMBL23452304 | 0.77 | MASP2 (0.65) | MASP2CYP3A4F2F11KLKB1 | |
| SCHEMBL28593491 | 0.76 | MASP2 (0.59) | MASP2CYP3A4F2F11KLKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7144899-B2 | Thrombin inhibitors | MERCK & CO., INC. (US) | 2006-12-05 | — | — | US | disclosed |
| US-20040073025-A1 | Thrombin inhibitors | MERCK SHARP & DOHME CORP. | 2004-04-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040073025-A1 | Thrombin inhibitors | F2, F11, F10 | MASP2 673/4885CYP3A4 2153/4885F2 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.